Drugs, doses, and durations of intraperitoneal chemotherapy: standardizing HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma. (Record no. 2398)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01995nam a22002777a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 170614s20172017 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0265-6736 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) | |
PMID | 28540826 |
245 ## - TITLE STATEMENT | |
Title | Drugs, doses, and durations of intraperitoneal chemotherapy: standardizing HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma. |
251 ## - Source | |
Source | International Journal of Hyperthermia. :1-34, 2017 Feb 08 |
252 ## - Abbreviated Source | |
Abbreviated source | Int J Hyperthermia. :1-34, 2017 Feb 08 |
253 ## - Journal Name | |
Journal name | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Year | 2017 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Manufacturer | FY2017 |
266 ## - Date added to catalog | |
Date added to catalog | 2017-06-14 |
520 ## - SUMMARY, ETC. | |
Abstract | Peritoneal surface malignancy (PSM) is a common manifestation of digestive and gynecologic malignancies alike. At present, patients with isolated PSM are treated with a combination therapy of cytoreductive surgery (CRS) and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC). The combination of CRS and intraperitoneal (IP) chemotherapy should now be considered standard of care for PSM from appendiceal epithelial cancers, colorectal cancer and peritoneal mesothelioma. Although there is a near universal standardization regarding the CRS, we are still lacking a much-needed standardization amongst the various IP chemotherapy treatment modalities used today in clinical practice. Pharmacologic evidence should be generated to answer important questions raised by the myriad of variables associated with IP chemotherapy. |
546 ## - LANGUAGE NOTE | |
Language note | English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | IN PROCESS -- NOT YET INDEXED |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME | |
Institution | Washington Cancer Institute |
657 ## - INDEX TERM--FUNCTION | |
Medline publication type | Journal Article |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Local Authors | Sugarbaker, Paul H |
790 ## - Authors | |
All authors | Lemoine L, Sugarbaker P, Van der Speeten K |
856 ## - ELECTRONIC LOCATION AND ACCESS | |
DOI | <a href="https://dx.doi.org/10.1080/02656736.2017.1291999">https://dx.doi.org/10.1080/02656736.2017.1291999</a> |
Public note | https://dx.doi.org/10.1080/02656736.2017.1291999 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Koha item type | Journal Article |
Item type description | Article |
Withdrawn status | Lost status | Damaged status | Not for loan | Collection | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MedStar Authors Catalog | MedStar Authors Catalog | 06/14/2017 | 28540826 | 28540826 | 06/14/2017 | 06/14/2017 | Journal Article |